Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years
Sponsor: Essilor International
Summary
The goal of this clinical investigation is to learn how much a new generation of myopia control lens (MCL1 - Myopia Control Lens 1) is helpful in reducing myopia progression in children from 6 to 14 yo. The main questions it aims to answer is: How much this new generation of lens, called MCL1, slows down the growth of the eye? Researchers will compare MCL1 to a former generation of myopia control lens (i.e. MCL2) but with better vision quality. Participants will: * Wear MCL1 on right eye and MCL2 on left eye for 6 months and MCL2 on rigth eye and MCL1 on left eye for the next 6 months; * Visit the hospital at 6 and 12 months for tests; * Answer weekly questionnaires on compliance wearing glasses, quality of vision and out-of-school activities.
Official title: Evaluation of the Effectiveness of a New Generation of Myopia Control Lens, Producing a Higher Myopic Control Signal Than That Produced by a Previous Generation Lens, on the Progression of Myopia in Children Aged 6 to 14 Years
Key Details
Gender
All
Age Range
6 Years - 14 Years
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2026-03
Completion Date
2028-05
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
MCL1
Myopia Control Lens 1 (MCL 1) is an ophthalmic lens intended to slow down eye growth in children.
MCL2
Myopia Control Lens 2 (MCL 2) is an ophthalmic lens intended to slow down eye growth in children.
Locations (1)
Département d'Ophtalmologie, Hôpital Fondation Adolphe de Rothschild
Paris, France